Acute pancreatitis in Soweto, South Africa: Relationship between trypsinogen load, trypsinogen activation, and fibrinolysis

American Journal of Gastroenterology

Volumn 97, Issue 4, 2002, Pages 883-892

  Segal, Isidor ^a   Chaloner, Christopher ^b   Douglas, Jessica ^b   John, Klaus Dieter ^a   Zaidi, Amir ^b   Cotter, Lawrence ^b   Appelros, Stefan ^c   Borgström, Anders ^c   Braganza, Joan M ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA 2 MACROGLOBULIN; CARBOXYPEPTIDASE B; FIBRIN; PLASMIN; PROTEINASE INHIBITOR; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR; TRYPSINOGEN;

ACINAR CELL; ACUTE PANCREATITIS; ADULT; AGED; ALCOHOL CONSUMPTION; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FIBRINOLYSIS; HUMAN; INFLAMMATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SOUTH AFRICA; URINALYSIS;

ACUTE DISEASE; ADULT; AGED; AGED, 80 AND OVER; FEMALE; FIBRIN; FIBRINOLYSIS; HUMANS; MALE; MIDDLE AGED; PANCREATITIS, ALCOHOLIC; PROTEASE INHIBITORS; SEVERITY OF ILLNESS INDEX; SOUTH AFRICA; TRYPSINOGEN;

EID: 0036117775     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(02)03960-6     Document Type: Article

References (61)

1. Pancreatitis in Soweto, South Africa: Focus on alcohol-related disease
2. Acute pancreatitis in Sowetan Africans. A disease with high mortality and morbidity
3. Hypercoagulability in acute pancreatitis
4. The relationship of coagulation factors to clinical complications of acute pancreatitis
5. Haematological abnormalities in acute pancreatitis. A prospective study
6. Pulmonary function and fibrinogen metabolism in acute pancreatitis
7. Studies of pathological plasma proteolysis in patients with acute pancreatitis. A preliminary report
8. Systemic involvement in pancreatic damage: Coagulation and fibrinolysis
9. 1-protease inhibitor complexes in serum and clinical course of acute pancreatitis
10. 1 antitrypsin as diagnostic and prognostic marker of acute pancreatitis; Clinical study in consecutive patients
11. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis
12. Urinary trypsinogen activation peptide (TAP) predicts severity in patients with acute pancreatitis
13. Activation peptide of procarboxypeptidase B in serum and urine in acute pancreatitis
14. Mechanism and role of trypsinogen activation in acute pancreatitis
15. Early prediction of severity of acute pancreatitis by urinary trypsinogen activation peptide: A multicentre study
16. Time-resolved immunofluorometric assays for trypsinogen-1 and 2 in serum reveal preferential elevation of trypsinogen-2 in pancreatitis
17. Rapid measurement of urinary trypsinogen-2 as a screening test for acute pancreatitis
18. Different patterns in immunoreactive anionic and cationic trypsinogen in urine and serum in human acute pancreatitis
19. Role of enzyme inhibitors in acute pancreatitis and rationale for their therapeutic use
20. Acute pancreatitis
21. Intracellular transport of pancreatic enzymes
22. Pathophysiology of pancreatitis
23. Activation of pancreatic zymogens: Normal activation, premature intrapancreatic activation, protective mechanisms against inappropriate activation
24. A clinical and morphologic study of forty-two cases of fatal acute pancreatitis
25. 1 antitrypsin complex values identify endoscopic retrograde cholangiopancreatography induced pancreatitis with high accuracy
26. Is activation of the pancreatic enzymes an important pathophysiological mechanism in ERCP induced pancreatitis
27. Serial alterations in the forms of immunoreactive trypsin in plasma from patients with acute pancreatitis
28. Generation and possible significance of trypsinogen activation peptides in experimental acute pancreatitis in the rat
29. Activation of trypsinogen and plasminogen by thrombin preparations
30. Studies on the activation of canine trypsinogens in vitro
31. Fibrinolysis and the plasma carboxypeptidase
32. A rapid immunoassay (EIA) for the quantitative determination of soluble fibrin in plasma
33. The detection of D-dimer in plasma by enzyme immunoassay: Improved discrimination is obtained with a more specific signal antibody
34. The relationship of soluble fibrin and cross-linked fibrin degradation products to the clinical course of myocardial infarction
35. Discordant inflammatory responses in Sowetan Africans with acute pancreatitis
36. Evidence for oxidative stress in African blacks with acute pancreatitis
37. Post-ERCP pancreatitis as a model for cytokine induced acute phase response in acute pancreatitis
38. Urine trypsinogen-2 as marker of acute pancreatitis
39. Activation peptides in acute pancreatitis
40. Pancreatic acinar cell injury after clot-dissolution therapy in myocardial infarction
41. A preliminary report on urinary BT-PABA/PAS excretion index, serum pancreatic isoamylase and faecal chymotrypsin tests of pancreatic dysfunction in Sowetan Africans
42. Interstitial trypsinogen release and its relevance to the transformation of mild into necrotising pancreatitis in rats
43. 2+ spiking in rat exocrine pancreas
44. Xenobiotic metabolism, oxidant stress and chronic pancreatitis
45. Differences in plasminogen activator inhibitor 1 activity between blacks and whites may be diet related
46. Inactivation of plasminogen activator inhibitor by oxidants
47. In vitro oxidative damage to tissue-type plasminogen activator: A selective modification of the biological functions
48. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis
49. A new enzyme immunoassay for soluble fibrin in plasma, with a high discriminating power for thrombotic disorders
50. Antithrombin titre in acute pancreatitis
51. Local activation of coagulation initially after repercussion of human pancreas grafts
52. Modulators of coagulation. A critical appraisal of their role in sepsis
53. Contact system: A vascular biology modulator with profibrinolytic, antiadhesive, and proinflammatory attributes
54. Alpha 2 macroglobulin state in acute pancreatitis. Raised values of alpha 2 macroglobulin-protease complexes in severe and mild attacks
55. Consumptive coagulopathy, fibrinolysis and protease-antiprotease interactions during acute human pancreatitis
56. 2 macroglobulin complexes and components of the contact system from the peritoneal cavity in patients with severe pancreatitis
57. Plasma plasminogen activator-1 in angina pectoris. Influence of plasma insulin and acute-phase response
58. Mast cell: Pivotal player in lethal acute pancreatitis
59. Towards a novel therapeutic strategy in acute pancreatitis. Part 2: Principles and potential practice